Orbital floor fractures are a type of facial fracture that affects the bones of the lower eye socket. These fractures can be caused by blunt force trauma to the face, such as a punch or a fall, and can cause serious complications if not treated promptly. Traditionally, orbital floor fractures have been treated with reconstructive surgery, but this approach carries a risk of complications, including infection, scarring, and impaired vision. Fortunately, there is a new hope for treating orbital floor fractures, with the potential to revolutionize the way these injuries are treated.
The traditional approach to treating orbital floor fractures has been to surgically repair the fracture. This involves using a combination of metal plates and screws to reconstruct the fractured bone. While this approach can be successful in some cases, it carries a number of serious risks and complications. Infection is a common complication of reconstructive surgery, as is scarring, which can be permanent. In addition, the metal plates and screws used in the reconstructive surgery can cause long-term pain and discomfort. Finally, there is a risk of impaired vision, as the metal plates and screws can interfere with the eye’s ability to move.
Fortunately, there is a new hope for treating orbital floor fractures. This new approach involves the use of a minimally invasive procedure known as transconjunctival orbital floor repair. This procedure involves making a small incision in the lower eyelid and inserting a special implant made of a material known as polymethylmethacrylate (PMMA). The implant is then secured to the bone using a combination of sutures and screws.
The transconjunctival orbital floor repair procedure has a number of advantages over traditional reconstructive surgery. Firstly, it is less invasive, meaning that there is a reduced risk of infection and scarring. Secondly, the procedure is quicker and less painful, making it a more attractive option for patients. Finally, the PMMA implant used in the procedure does not interfere with the eye’s ability to move, meaning that there is no risk of impaired vision.
The transconjunctival orbital floor repair procedure has the potential to revolutionize the treatment of orbital floor fractures. This minimally invasive procedure is less risky and more comfortable for patients, and can be performed quickly and effectively. In addition, the use of the PMMA implant means that there is no risk of impaired vision. As such, the transconjunctival orbital floor repair procedure is a safe and effective alternative to traditional reconstructive surgery, and is likely to become the preferred treatment for orbital floor fractures in the future.
Orbital floor fractures can be a serious and potentially life-threatening injury. Fortunately, there is now a new hope for treating these fractures, with the potential to revolutionize the way these injuries are treated. The transconjunctival orbital floor repair procedure is a minimally invasive procedure that is less risky and more comfortable for patients, and can be performed quickly and effectively. As such, this procedure is likely to become the preferred treatment for orbital floor fractures in the future.
1.
Does pollution cause cancer?
2.
AI is equally capable of reading breast cancer scans as human radiologists.
3.
EVP Beats Cisplatin for Resectable MIBC
4.
New research points out a promising strategy for treating metastatic medulloblastoma
5.
Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection
3.
Impact of Hormone Therapy Cessation on Tumor Growth: Case Study of Ki-67 Reduction
4.
Unraveling the Mysteries of Lymphoma: A Journey into the Unknown
5.
Refining AML Survival: Prognostic Factors, Therapies, and Stem Cell Strategies Reviewed
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part III
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
5.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation